Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin

This study has been completed.
Information provided by:
Sanofi Identifier:
First received: August 23, 2005
Last updated: January 10, 2011
Last verified: January 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: August 2005
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):